Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
Yan Su, Hai Lin, Ying Tu, et al.
Chemical Science (2022) Vol. 13, Iss. 5, pp. 1428-1439
Open Access | Times Cited: 23

Showing 23 citing articles:

Mitochondria-targeted smart AIEgens: Imaging and therapeutics
Haidong Li, Heejeong Kim, Cheng Zhang, et al.
Coordination Chemistry Reviews (2022) Vol. 473, pp. 214818-214818
Closed Access | Times Cited: 94
Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
Peili Cen, Jiani Huang, Chentao Jin, et al.
Aggregate (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 92
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 83
Amphiphilic quinoline-malononitrile AIE probes: From molecule design to bio-applications
Zhirong Zhu, Yiqi Shi, Chenxu Yan, et al.
Coordination Chemistry Reviews (2025) Vol. 533, pp. 216550-216550
Closed Access | Times Cited: 2
Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death
Yu‐Qiang Zhao, Le Yu, Lanyun Zhang, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 12
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
TPP-based conjugates: potential targeting ligands
Sanya Batheja, Shruti Gupta, Kiran Kumar Tejavath, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103983-103983
Closed Access | Times Cited: 9
Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents
Mengdi Lv, Xiaoting Qian, Shijie Li, et al.
Journal of Inorganic Biochemistry (2022) Vol. 238, pp. 112057-112057
Closed Access | Times Cited: 24
Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition
Yan Su, Jin Yang, Mengmeng Wang, et al.
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112427-112427
Closed Access | Times Cited: 13
Near-infrared imaging for visualizing the synergistic relationship between autophagy and NFS1 protein during multidrug resistance using an ICT–TICT integrated platform
Wei Hu, Yifan He, Haixian Ren, et al.
Chemical Science (2024) Vol. 15, Iss. 16, pp. 6028-6035
Open Access | Times Cited: 5
Functional Upgrading of an Organo–Ir(III) Complex to an Organo–Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy
Mengmeng Wang, Dongping Deng, Anmin Zhou, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 10, pp. 4758-4769
Closed Access | Times Cited: 4
A mitochondria targeting Ir(III) complex triggers ferroptosis and autophagy for cancer therapy: A case of aggregation enhanced PDT strategy for metal complexes
Panpan Wang, Hongbao Fang, Mengmeng Wang, et al.
Chinese Chemical Letters (2024), pp. 110099-110099
Closed Access | Times Cited: 4
Recent progress on the organelle targeted AlEgens for bioimaging and treatment of diseases
Qihang Ding, Yan Luo, Jun Hu, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153395-153395
Closed Access | Times Cited: 4
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition
Guandong Zhang, Mengmeng Wang, Yan Su, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112574-112574
Closed Access | Times Cited: 3
Recent advances in the development of metallodrugs for cancer chemoimmunotherapy
Fangmian Wei, Jinzhe Liang, Xing‐Can Shen, et al.
Coordination Chemistry Reviews (2024) Vol. 526, pp. 216319-216319
Closed Access | Times Cited: 3
Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition
Jin Yang, Mengmeng Wang, Dongping Deng, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 11, pp. 5235-5245
Closed Access | Times Cited: 2
Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses
Suying Li, Shuaiqi Feng, Yan Chen, et al.
Journal of Inorganic Biochemistry (2024) Vol. 260, pp. 112696-112696
Closed Access | Times Cited: 2
Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications
Jing Wang, Xueliang Wang, Kai Yang, et al.
Biosensors (2022) Vol. 12, Iss. 9, pp. 683-683
Open Access | Times Cited: 10
Self-Assembly Mitochondria-Targeting Donor–Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy
Wenjuan Gao, Mengmeng Wang, Yan Su, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 2, pp. 722-732
Closed Access | Times Cited: 5
Regulation of Bacterial Behavior by Light and Magnetism Mediated by Mesoporous Silica-Coated MnFe2O4@CoFe2O4 Nanoparticles
Tian Deng, Fang-Chu Lin, Jeffrey I. Zink, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 50, pp. 56007-56017
Closed Access | Times Cited: 8
Three metal complexes with a pyridyl Schiff base: cytotoxicity, migration and mechanism of apoptosis
Feiya Zhou, Fangxin Gao, Qinghua Chang, et al.
Dalton Transactions (2022) Vol. 51, Iss. 39, pp. 14993-15004
Closed Access | Times Cited: 7
The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent
Lu Liu, Jun Chen, Mengmeng Wang, et al.
Journal of Inorganic Biochemistry (2022) Vol. 235, pp. 111913-111913
Closed Access | Times Cited: 5
An artesunate-modified half-sandwich iridium(iii) complex inhibits colon cancer cell proliferation and metastasis through the STAT3 pathway
Dongping Deng, Na Xu, Mengmeng Wang, et al.
RSC Chemical Biology (2024)
Open Access
Page 1

Scroll to top